Table 1 Characteristics of borderline malignancy and epithelial ovarian cancer cases
From: GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer
Variables | Number of patients (%) |
|---|---|
| Ā | N=162 |
Age (years) | 54.1 Ā± 12.5 |
Postmenopausal | 96 |
Premenopausal | 66 |
BMI | 22.0 Ā± 3.4 |
Histology Borderline malignancy | 10 (6.1%) |
Serous adenocarcinoma | 61 (37.6%) |
Endometrioid adenocarcinoma | 30 (18.5%) |
Mucinous adenocarcinoma | 19 (11.7%) |
Clear cell adenocarcinoma | 29 (17.9%) |
Other | 13 (8.0%) |
FIGO stage I | 49 (30.2%) |
āāāāāII | 14 (8.6%) |
āāāāāIII | 77 (47.5%) |
āāāāāIV | 22 (13.5%) |